Alerts will be sent to your verified email
Verify Email
IPCALAB
|
Ipca Laboratories
|
Ajanta Pharma
|
Gland Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
13.55 % | 21.63 % | 12.02 % |
|
5yr Avg Net Profit Margin
|
11.88 % | 19.77 % | 20.79 % |
|
Price to Book
|
4.99 | 8.08 | 3.36 |
|
P/E
|
44.5 | 32.94 | 39.97 |
|
5yr Avg Cash Conversion Cycle
|
54.3 Days | -102.34 Days | 69.81 Days |
|
5yr Average Interest Coverage Ratio
|
50.79 | 108.5 | 183.05 |
|
5yr Avg ROCE
|
17.31 % | 27.48 % | 16.55 % |
|
5yr Avg Operating Profit Margin
|
19.8 % | 27.65 % | 29.26 % |
|
5 yr average Debt to Equity
|
0.17 | 0.0 | 0.01 |
|
5yr CAGR Net Profit
|
-8.34 % | 7.08 % | -6.87 % |
|
5yr Average Return on Assets
|
9.41 % | 16.51 % | 10.65 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
44.72 % | 66.26 % | 51.83 % |
|
Share Pledged by Promoters
|
0.0 | 14.12 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-1.57 % | -4.22 % | -6.04 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.2 % | 3.84 % | 15.13 % |
|
Ipca Laboratories
|
Ajanta Pharma
|
Gland Pharma
|
|---|